Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Katri Koli"'
Autor:
Eva Sutinen, Henrik Wolff, Jari Räsänen, Tapio Vehmas, Katri Koli, Eeva Kuosma, Sanna Laaksonen, Jarmo A. Salo, Kirsti Husgafvel-Pursiainen, Ilkka Ilonen, Marjukka Myllärniemi
Publikováno v:
Acta Oncologica. 58:38-44
Background: Malignant pleural mesothelioma (MPM) is a rare occupational cancer with a poor prognosis. Even with a multimodality treatment approach, the treatment outcomes remain unsatisfactory. The use of asbestos has been banned in most developed co
Autor:
Janne Raula, Ville Vartiainen, Nurcin Ugur, Luis M. Bimbo, Jenni Viinamäki, Marjukka Myllärniemi, Katri Koli, Esko I. Kauppinen, Eva Sutinen, Janne T. Backman, Emmi I. Joensuu
Publikováno v:
INTERNATIONAL JOURNAL OF PHARMACEUTICS. 544(1):121-128
The aim of this work was to study the antifibrotic effect of pulmonary administration of tilorone to lung fibrosis. L-leucine coated tilorone particles were prepared and their aerosolization properties were analyzed using two dry powder inhalers (Eas
Autor:
Mira Tissari, Irene Ylivinkka, Katri Koli, Pernilla von Nandelstadh, Mikko Rönty, Miao Yin, Kaisa Lehti, Jenni A. Tamminen, Marko Hyytiäinen, Marjukka Myllärniemi
Publikováno v:
Oncotarget
// Miao Yin 1, 2 , Mira Tissari 1, 2 , Jenni Tamminen 1, 2 , Irene Ylivinkka 1 , Mikko Ronty 3 , Pernilla von Nandelstadh 4 , Kaisa Lehti 4, 5, 6 , Marko Hyytiainen 4 , Marjukka Myllarniemi 7 and Katri Koli 1, 2 1 Research Programs Unit, Translationa
Autor:
Eeva Rouvinen, Marjukka Myllärniemi, Katri Koli, Helena Lauri, Jari Räsänen, Eva Sutinen, Ilkka Ilonen, Karl B. Lemström, Juuso Paajanen, Olli Ritvos, Tommi Järvinen, Hely Ollila
Publikováno v:
Clinical lung cancer. 21(3)
Activin A has previously been associated with cancer cachexia and in vitro resistance to platinum-based chemotherapy. We studied circulating activin A concentrations as well as activin B and their antagonists' follistatin/follistatin-like 3 in presur
Autor:
Hannu Kankaanranta, Eija-Riitta Salomaa, Katri Koli, Riitta Kaarteenaho, Ulla Hodgson, Tero Vahlberg, Jaana Kaunisto, Marjukka Myllärniemi
Publikováno v:
ERJ Open Research, Vol 5, Iss 3 (2019)
ERJ Open Research
ERJ Open Research
Idiopathic pulmonary fibrosis (IPF) is characterised by unpredictable disease course and poor survival. After the introduction of novel antifibrotic drugs, the prognosis of patients with IPF is probably changing. FinnishIPF, a nationwide registry of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::408a496a8e3bb18ddd93fa7a7bd83a51
http://hdl.handle.net/10138/313003
http://hdl.handle.net/10138/313003
Autor:
Ville Vartiainen, Katri Koli, Veronika Rezov, Emmi I. Joensuu, Chang Li, Mikko Rönty, Miao Yin, Marjukka Myllärniemi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Malignant mesothelioma is an aggressive cancer with poor prognosis. It is characterized by prominent extracellular matrix, mesenchymal tumor cell phenotypes and chemoresistance. In this study, the ability of pirfenidone to alter mesothelioma cell pro
Publikováno v:
Molecular Endocrinology. 29:1787-1791
Recently, several LH/human chorionic gonadotropin (hCG) receptor-independent activities for hCG have been described, including activation of the TGF-β receptor (TGFβR) by hyperglycosylated hCG and stimulation of trophoblast invasion. Because the hC
Autor:
Esko I. Kauppinen, Amanda Attobrah, Katri Koli, Marjukka Myllärniemi, Ville Vartiainen, Janne Raula
Publikováno v:
QJM: An International Journal of Medicine.
Idiopathic pulmonary fibrosis (IPF) is a severe progressive fibrotic lung disease. During the past few years two orally administered drug candidates (pirfenidone and nintedanib) for slowing the progression of IPF were approved for clinical practice.
Autor:
Katri Koli, Sirpa Loukovaara, Johanna Liinamaa, Kaisa Lehti, Timo Pessi, Kirsi-Tiina Kukkonen, Alexandra Robciuc, Juha M. Holopainen, Matti Jauhiainen, Jorma Keski-Oja, Ilkka Immonen
Publikováno v:
Acta Ophthalmologica. 91:531-539
Purpose: Angiogenesis in diabetic retinopathy (DR) is a multifactorial process regulated by hypoxia-induced growth factors and inflammatory cytokines. In addition to the angiogenic switch, the proteolytic processing and altered synthesis of the extra
Publikováno v:
Journal of Cellular Biochemistry. 113:2234-2247
The inhalation of asbestos fibers is considered to be highly harmful, and lead to fibrotic and/or malignant disease. Epithelial-to-mesenchymal transition (EMT) is a common pathogenic mechanism in asbestos associated fibrotic (asbestosis) and malignan